Search Within

Ping Chi

Formats
  1. Journal Article (91)
  2. Meeting Abstract (81)
  3. Review (2)
  4. Miscellaneous (1)
Groups
  1. Department of Medicine (175)
  2. GSK Faculty (175)
  3. Human Oncology and Pathogenesis Program (175)
  4. Sarcoma Service (175)
  5. Solid Tumor Oncology Division (175)
  6. Tow Center for Developmental Oncology (TCDO) (175)

More Groups

People
  1. William Tap (70)
  2. Cristina Antonescu (67)
  3. Sandra D'Angelo (60)
  4. Mrinal Gounder (58)
  5. Mary Keohan (57)
  6. Mark Dickson (56)

More People

Years
  1. 2025 (6)
  2. 2024 (18)
  3. 2023 (19)
  4. 2022 (30)
  5. 2021 (20)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (18)
  3. Annals of Oncology (14)
  4. Cancer Research (11)
  5. Genes Chromosomes and Cancer (5)
  6. JCO Precision Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (42)
  2. American Association for Cancer Research (35)
  3. Oxford University Press (20)
  4. Nature Publishing Group (16)
  5. Elsevier Inc. (8)
  6. Cell Press (6)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements
    Journal Article

    Chang, J. C.; Zhang, L.; Drilon, A. E.; Chi, P.; Alaggio, R.; Borsu, L.; Benayed, R.; Travis, W. D.; Ladanyi, M.; Antonescu, C. R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618
    Meeting Abstract

    George, S.; Heinrich, M. C.; Razak, A. R. A.; Chi, P.; Gordon, M. S.; Ganjoo, K. N.; von Mehren, M.; Somaiah, N.; Trent, J. C.; Su, Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pharmacokinetic (PK), safety, and tolerability profile of DCC-2618 in a phase I trial supports 150mg QD selected for a pivotal phase III trial in gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Janku, F.; Heinrich, M.; Razak, A.; Gordon, M.; Chi, P.; Ganjoo, K.; von Mehren, M.; Somaiah, N.; Lee, J.; Kuida, K.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Ran, L.; Chen, Y.; Wong, W. P. E.; Li, D.; Cao, Z.; Shukla, S.; Xie, Y.; Zheng, D.; Koche, R. P.; Antonescu, C. R.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
    Meeting Abstract

    George, S.; Heinrich, M.; Chi, P.; Razak, A.; von Mehren, M.; Gordon, M.; Ganjoo, K. N.; Somaiah, N.; Trent, J. C.; Rodon Ahnert, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Aberrant activation of a gastrointestinal transcriptional circuit in prostate cancer mediates castration resistance
    Meeting Abstract

    Shukla, S.; Cyrta, J.; Murphy, D.; Walczak, E.; Ran, L. L.; Agrawal, P.; Xie, Y.; Chen, Y.; Wang, S.; Zhan, Y.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers
    Journal Article

    Chen, Y.; Chi, P.
    Journal of Hematology & Oncology (2018)

    Fulltext@MSK | Save
  • A clinicopathologic study of head and neck malignant peripheral nerve sheath tumors
    Journal Article

    Owosho, A. A.; Estilo, C. L.; Huryn, J. M.; Chi, P.; Antonescu, C. R.
    Head and Neck Pathology (2018)

    Fulltext@MSK | Save